ORITAVANCIN IS ASSOCIATED WITH IMPROVED ECONOMIC OUTCOMES VERSUS DALBAVANCE IN PATIENTS WITH ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS TREATED IN A HOSPITAL OPAT SETTING- RESULTS FROM AN OBSERVATIONAL DATABASE
Abstract
Authors
W. Fan S. Armstrong S. Plent